top of page
BG_01_edited.jpg

A safety oriented and flexible approach to cell therapy 

AddGraft is deploying cutting edge genetic treatments
to address some of the biggest problems facing our world today

Image by Drew Beamer
Test tubes.png

TECHNOLOGY 

All Videos

All Videos

Watch Now
ABOUT
Image by National Cancer Institute

ABOUT

AddGraft Therapeutics is redefining the therapy production and delivery landscape with our one-of-a-kind approach to cell therapy.


Our unique technology promises to circumvent issues associated with toxicity, dose control, eligibility, and large transgene size that are keeping current forms of cell / gene therapy from reaching patients today.

We aim to translate our promising pre-clinical
work into the clinic to help people around the world better face a variety of disease with new hope.

TECHNOLOGY
TEAM

OUR TEAM

Picture1.jpg

Ryan Meyers

Picture2.png

Dr. Ming Xu

Chief Executive Officer
Chief Science Officer

Ryan is a skilled STEM leader with significant experience in management consulting and venture capital. Prior to

co-founding AddGraft, Ryan helped lead healthcare organizations through significant M&A activities.

Here he developed expertise in project management, team leadership and strategic decision making. Ryan has his MBA from the Booth School of Business at the University of Chicago.

Dr. Ming Xu is a professor of neurobiology in the Biological Science Division at the University of Chicago.

Over the last 25 years, Dr. Xu’s laboratory has worked to understand the mechanisms of drug addiction and aimed to find possible treatment strategies. With over 100 publications in the field of Neurobiology,

Dr. Xu is world class expert in the study of Neurological Disease and specifically addiction.

Picture3.png

Dr. Xiaoyang Wu

Chief Technology Officer

Dr. Xiaoyang Wu is an associate professor of tissue engineering in the Biological Science Division at the University of Chicago. Dr. Wu’s long-term interest is to explore cell signaling and the molecular mechanisms controlling somatic stem cell behavior and somatic gene therapy. His laboratory has significantly advanced our understanding of how skin injuries activate quiescent epidermal stem cells to proliferate and migrate to repair a wound.

PROGRAMS
Booth.png
Polsky.png
CDL.png
Biofoundry.png
I2I.png
NJII.jpg
Phacil.png
Compass.png
IfastC.png

PROGRAMS,
AFFILIATIONS
AND AWARDS

WBC.png
UC Med.png
Hello Tomorrow.png
HT DTP.png
CONTACT US
bottom of page